PGY3 Internal Medicine @UofOklahoma @OUhealth | MBBS grad '22, @UCMSofficial I Passionate for Hematology Oncology 🎗️ MATCH 2027 I Traveller 🏝 I Cat Dad 🐱

New Delhi, India
Joined August 2011
Happy to share that our phase 1 study just got funded with a $100,000 grant from @StephensonCC. Beyond grateful to @Phase1Onc for the mentorship and the chance to come on as co-investigator on my first clinical trial. A lot to learn 🧑‍🔬 @ResearchOU @OU_internalmed
12
2
2
45
6,317
Interesting!
Cancer patients with the same diagnosis often have very different tumor biology. Molecular testing can reveal underlying differences, but that's slow and expensive. Introducing Holon-S1, our platform to predict genes and biomarkers from routine pathology slides. • beats two other models at predicting spatial gene activity in a controlled comparison • has identified potentially novel biomarkers in breast cancer and colon cancer • evaluated across 16 organ types and more than 15 scanners, using slides from both formalin-fixed, paraffin-embedded and fresh-frozen tissue. We believe Holon-S1 has the potential to help researchers find new biomarkers in slides they already have, discover treatment targets, and bring more personalized cancer care within reach!
132
What a crazy time to be alive ! Those sci-fi movies are slowly becoming a reality.
Introducing Griffin, the first model to pass the video Turing test. 48% of people who talked to it live thought it was a real human. Previous systems have had a pass rate <3%. It is #1 on NVIDIA's benchmark for full-duplex AI video. It’s the first Human Interaction Model (HIM).
Readers added context they thought people might want to know
The 48% figure and "video Turing test" claim are from Tavus's own study of 54 one-minute calls, not independently verified or using a standard protocol. Griffin-Lite leads NVIDIA's VideoFDB benchmark on their public leaderboard. cellcog.ai/blog/tavus-gri… research.nvidia.com/labs/amri/proj… tech-ish.com/2026/10/02/tav…
1
110
Ujjwal Soni retweeted
Introducing Griffin, the first model to pass the video Turing test. 48% of people who talked to it live thought it was a real human. Previous systems have had a pass rate <3%. It is #1 on NVIDIA's benchmark for full-duplex AI video. It’s the first Human Interaction Model (HIM).
Readers added context they thought people might want to know
The 48% figure and "video Turing test" claim are from Tavus's own study of 54 one-minute calls, not independently verified or using a standard protocol. Griffin-Lite leads NVIDIA's VideoFDB benchmark on their public leaderboard. cellcog.ai/blog/tavus-gri… research.nvidia.com/labs/amri/proj… tech-ish.com/2026/10/02/tav…
3,441
4,280
5,641
39,202
21,192,658
Congratulations, Dr. Soni! So well deserved. We are incredibly proud of you!👏🎉
Had an amazing time presenting our work at the OSCO conference today at @StephensonCC. Humbled and honored to receive 1st prize for our poster on SMAD4 alterations as a predictor of neoadjuvant chemotherapy response in PDAC. Always grateful to my mentor @Phase1Onc. @OU_internalmed
1
4
357
Had an amazing time presenting our work at the OSCO conference today at @StephensonCC. Humbled and honored to receive 1st prize for our poster on SMAD4 alterations as a predictor of neoadjuvant chemotherapy response in PDAC. Always grateful to my mentor @Phase1Onc. @OU_internalmed
2
1
2
19
2,344
I am curious to see how medicine will look like in next 10 years !
New from @GoogleResearch and @GoogleDeepMind: AMIE can now conduct real-time video consultations. In a randomized study using simulated consultations, it met clinical performance benchmarks, showing AI’s potential to expand telehealth access. Learn more: goo.gle/4bHRK2v
538
Things I’m eagerly looking forward to in 2026: 1.Working on my first ever clinical trial (still can’t believe it) 2.iOS 27 and macOS Golden Gate (Finally getting that smart Siri) 💻 3.Heme/Onc fellowship interviews at my dream programs 🤞 4.GTA 6 !!! (FINALLY)
1
9
905
Ujjwal Soni retweeted
Being able to deliver a great talk/presentation is really important for academic success. Especially in medicine. 1) Know your audience: If it’s clinicians, keep your talk relevant. You don’t need to impress them with all that you know about complex mechanism of action pathways, unavailable genomic tests, and a lot of phase I investigational stuff. 2) Razor focus on the title of the talk: Easy concept but one is see even experts miss. If the talk is on how you treat, tell them how you treat. Don’t spend half the time on pathogenesis or the latest research in your lab. 3) Keep slides simple: I often see entire posters on a single slide. It’s better to show one summary figure or a simple table and keep the audience engaged with your voice and explanation 4) Clarity: An essential ingredient. speak into the mic. Be crystal clear; Build up the story so even someone not in your field will be able to follow along. 5) Know your subject extremely well: The most important of all. You cannot do 1-4 without this. Being complex is easy. Simple is hard. Simple comes only with a really strong command of the subject and the data. Plan your opening and ending. Rest has to be conversational and not reading off the slides. Takes time and practice. Chime in if you have other thoughts or ideas.
13
46
3
219
17,000
This means a great deal coming from you @Nischistocyte. Any growth you saw during PGY2 came from getting to learn alongside people like you early in training. Grateful for the mentorship then and the support now. 😇
When I worked with Ujjwal, I felt like I was working with a junior fellow while he was in the initial part of PGY2 🎉 He is a genius when it comes to being a physician, a star when it comes to research, and a highly reliable team member! Any HemOnc program will be lucky to recruit him 😎✨
7
1,340
Finally submitted my application for Hematology Oncology Fellowship Match 2026!! Beyond excited for the road ahead and to spend my career caring for patients with cancer and building better treatments. Grateful for the mentors who got me here. 🎗️ @RyanNipp @Phase1Onc @Taha_CancerDoc @chitkaramd @Nischistocyte #ERASFellowshipMatch2026 #HematologyOncology
6
4
1
37
3,780
Chiefs setting the bar way too high for us. Congratulations Dr Nasir 🤩
As I graduate from the OU Internal Medicine Residency Program, I am incredibly honored to receive the Humanism in Medicine Award and Resident Research Award. Thank you to the OU Internal Medicine family for three unforgettable years of learning, growth, mentorship, and friendship. I am especially grateful to Dr. @ZainAsadCardOnc and Dr.@CASivaram1 for their guidance, support, and belief in me throughout this journey. To my co-residents, faculty, patients, and loved ones, thank you for helping shape the physician and person I am today. @OUdoim @OU_internalmed
1
5
630
Congratulations Dr Lam !! 👏👏
Thank you so much for highlighting our work, @crisbergerot! I am so excited to present about longitudinal coping among early phase cancer clinical trial participants at #ASCO26, and I am especially honored to have been awarded a @ConquerCancerFd for Merit Award for this work🥹
1
12
615
Ujjwal Soni retweeted
My co-chiefs and I presented at @OUdoim Grand Rounds this afternoon and shared many of our initiatives throughout our CMR year with @OU_internalmed! What an honor it has been to serve our program and establish foundations to pave way for future residents🫶
7
6
1
24
3,068
Thank you Dr Maryam !! Learning from the best !!!
Congratulations! So well deserved and only the beginning for Dr. Soni
1
635
Thank you Chief !!! 😄
So proud of you, Ujjwal! An incredible and well-deserved achievement. Excited to see all the amazing work ahead and grateful to watch your journey continue to grow.
1
451
Presenting our poster at NCCN Annual Conference 2026 in Orlando @NCCN @RyanNipp
1
3
1
18
1,427
Ujjwal Soni retweeted
💬 Viewpoint: Mass abstract submissions in #MedEd have led to inflated metrics, less meaningful research, and misaligned incentives for trainees and institutions. ja.ma/4qlJES1
3
133
34
434
193,938
Our shining 🌟 fellow Dr Tiwari and resident Dr Arepalli got published in NEJM 🫡
Replying to @NEJM
@NEJM recently published a Letter to the Editor by @ouhealth and @StephensonCC HemOnc Fellow Nishant R. Tiwari, MD @Nischistocyte (senior author), IM Resident Satya Arepalli, MD, and Professor James N. George, MD, on Fetal Hereditary TTP 👏 nejm.org/doi/pdf/10.1056/NEJ…
1
1
7
2,799